First-in-human evaluation of [<sup>18</sup>F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [<sup>68</sup>Ga]Ga-PSMA-617.

Ann Med · 2026 · PMC13276814 · PMID 42304982

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

53.8%) did not reach statistical significance (all p > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

First-in-human evaluation of [&lt;sup&gt;18&lt;/sup&gt;F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-617.

The sentences

First-in-human evaluation of [<sup>18</sup>F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [<sup>68</sup>Ga]Ga-PSMA-617.